Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests

Completed

Conditions studied: Embolism and Thrombosis, Infection, Inflammation

In brief

A Multicenter Study Conducted to Evaluate the Agreement between Fingerstick Whole Blood, Venous Whole Blood and Plasma Determined on the LumiraDx Point of Care D-Dimer and Point of Care CRP Tests to Results on the Reference Analyzer

Key facts

Study ID

NCT04375982

Run by

LumiraDx UK Limited

People needed

111

Starts

2020-04-20

Expected to finish

2022-04-05

Last updated by the study team

2026-06-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• Rancho Paseo Medical Group — Banning, California, United States
• Centura Health Physician Group — Northglenn, Colorado, United States
• New Medical Healthcare — Wichita, Kansas, United States
• Diagnostic Clinic of Longview — Longview, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.